"AllerVie Clinical Research, an affiliate of AllerVie Health, conducts clinical studies in adult and pediatric patients, contributing to the advancement of new therapies for asthma, allergies, and other related immunological conditions. We provide access to otherwise unavailable treatments to patients suffering from these conditions. As the fastest growing national network of clinical research sites specializing in allergy and asthma-related studies, AllerVie Clinical Research provides comprehensive care to patients nationwide employing the most efficacious and up-to-date treatments—including biologics."

During the past decade, AllerVie Clinical Research conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "AllerVie Clinical Research" are "Chronic Inducible Urticaria" (1 trials), "Chronic Spontaneous Urticaria" (1 trials), "HAE" (1 trials), "Hereditary Angioedema" (1 trials) and "Peanut Allergy" (1 trials). Many other conditions were trialed in "AllerVie Clinical Research" in a lesser frequency.

Most popular intervention types in "AllerVie Clinical Research" are "Drug" (3 trials), "Biological" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Matching Placebo" (2 trials), "barzolvolimab" (2 trials), "CNP-201" (1 trials), "Dose 1 of BMN 331" (1 trials) and "Dose 2 of BMN 331" (1 trials). Other intervention names were less common.

The vast majority of trials in "AllerVie Clinical Research" are 4 trials for "All" genders.

Currently, there are NaN active trials in "AllerVie Clinical Research". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in AllerVie Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AllerVie Clinical Research, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".